• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对住院和门诊 COVID-19 患者的实验室标志物进行纵向监测。

Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.

机构信息

Institute of Tropical Medicine, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany.

Vietnamese-German Center for Medical Research, Hanoi, Vietnam.

出版信息

Sci Rep. 2021 Jul 14;11(1):14471. doi: 10.1038/s41598-021-93950-x.

DOI:10.1038/s41598-021-93950-x
PMID:34262116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8280222/
Abstract

Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 patients (n = 16) at home quarantine. Human D-dimer, C-reactive protein (CRP), ferritin, cardiac troponin I, interleukin-6 (IL-6) levels were measured on day 1, day 7, day 14 and day 28. All hospitalized patients were SARS-CoV-2 positive on admission, while all ambulatory patients were SARS-CoV-2 positive at recruitment. Hospitalized patients had higher D-dimer, CRP and ferritin, cardiac troponin I and IL-6 levels than ambulatory patients (p < 0.001, p < 0.001, p = 0.016, p = 0.035, p = 0.002 respectively). Hospitalized patients experienced significant decreases in CRP, ferritin and IL-6 levels from admission to recovery (p < 0.001, p = 0.025, and p = 0.001 respectively). Cardiac troponin I levels were high during the acute phase in both hospitalized and ambulatory patients, indicating a potential myocardial injury. In summary, D-dimer, CRP, ferritin, cardiac troponin I, IL-6 are predictive laboratory markers and can largely determine the clinical course of COVID-19, in particular the prognosis of critically ill COVID-19 patients.

摘要

早期检测 COVID-19 的严重形式对于及时对患者进行分类至关重要。我们对两组特征明确的患者进行了纵向随访,一组为住院的中重度 COVID-19 患者(n=26),另一组为在家隔离的轻度 COVID-19 患者(n=16)。在第 1、7、14 和 28 天测量了人类 D-二聚体、C 反应蛋白(CRP)、铁蛋白、肌钙蛋白 I、白细胞介素-6(IL-6)水平。所有住院患者入院时均为 SARS-CoV-2 阳性,而所有门诊患者在招募时均为 SARS-CoV-2 阳性。住院患者的 D-二聚体、CRP 和铁蛋白、肌钙蛋白 I 和 IL-6 水平均高于门诊患者(p<0.001,p<0.001,p=0.016,p=0.035,p=0.002 分别)。住院患者从入院到康复时 CRP、铁蛋白和 IL-6 水平显著下降(p<0.001,p=0.025 和 p=0.001 分别)。在住院和门诊患者中,肌钙蛋白 I 水平在急性期均较高,表明存在潜在的心肌损伤。总之,D-二聚体、CRP、铁蛋白、肌钙蛋白 I、IL-6 是预测性实验室标志物,可在很大程度上确定 COVID-19 的临床过程,特别是危重症 COVID-19 患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/c9313b8652cc/41598_2021_93950_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/e003453c21c6/41598_2021_93950_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/a356bf528c49/41598_2021_93950_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/3b5670d26476/41598_2021_93950_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/4ebe6266d5a8/41598_2021_93950_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/c9313b8652cc/41598_2021_93950_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/e003453c21c6/41598_2021_93950_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/a356bf528c49/41598_2021_93950_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/3b5670d26476/41598_2021_93950_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/4ebe6266d5a8/41598_2021_93950_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/8280222/c9313b8652cc/41598_2021_93950_Fig5_HTML.jpg

相似文献

1
Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.对住院和门诊 COVID-19 患者的实验室标志物进行纵向监测。
Sci Rep. 2021 Jul 14;11(1):14471. doi: 10.1038/s41598-021-93950-x.
2
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.在住院的 COVID-19 患者中,心脏损伤、炎症和凝血生物标志物与结局的纵向相关性。
J Mol Cell Cardiol. 2020 Oct;147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. Epub 2020 Aug 20.
3
SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.在因新冠肺炎住院的患者中,新冠病毒血症与炎症生物标志物相关,但与心血管生物标志物无关。
J Am Heart Assoc. 2021 May 4;10(9):e019756. doi: 10.1161/JAHA.120.019756. Epub 2021 Feb 18.
4
Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.炎症生物标志物在 COVID-19 感染患者中的应用:巴林经验。
Biomark Med. 2021 Jun;15(8):541-549. doi: 10.2217/bmm-2020-0422. Epub 2021 May 14.
5
Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID-19: Derivation and Validation of the HAT COVID-19 Mortality Risk Score.肌钙蛋白和其他生物标志物水平与 COVID-19 住院患者结局:HAT COVID-19 死亡率风险评分的推导和验证。
J Am Heart Assoc. 2021 Mar 16;10(6):e018477. doi: 10.1161/JAHA.120.018477. Epub 2020 Oct 30.
6
The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.COVID-19 住院患者的炎症生物标志物特征及其与患者预后的关系:一项单中心研究。
PLoS One. 2021 Dec 2;16(12):e0260537. doi: 10.1371/journal.pone.0260537. eCollection 2021.
7
Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19.血清铁蛋白和 D-二聚体轨迹对 COVID-19 患者的预后价值。
Viruses. 2021 Mar 5;13(3):419. doi: 10.3390/v13030419.
8
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients.细胞因子释放综合征的生物标志物可预测肾移植受者 COVID-19 疾病的严重程度和死亡率。
Transplantation. 2021 Jan 1;105(1):158-169. doi: 10.1097/TP.0000000000003480.
9
Study of Association of Infection-related Biomarkers and Inflammatory Cytokines with the Severity of Coronavirus Disease 2019: A Prospective Observational Study.新型冠状病毒病 2019 严重程度相关感染生物标志物和炎症细胞因子的关联研究:一项前瞻性观察研究。
J Assoc Physicians India. 2024 Aug;72(8):44-47. doi: 10.59556/japi.72.0616.
10
IL-6-based mortality risk model for hospitalized patients with COVID-19.基于 IL-6 的 COVID-19 住院患者死亡风险模型。
J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22.

引用本文的文献

1
Patterns of C1-Inhibitor Plasma Levels and Kinin-Kallikrein System Activation in Relation to COVID-19 Severity.与新冠病毒疾病严重程度相关的C1抑制物血浆水平及激肽-激肽释放酶系统激活模式
Life (Basel). 2024 Nov 21;14(12):1525. doi: 10.3390/life14121525.
2
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID).三肽素治疗重症 COVID-19 患者的疗效和安全性:一项随机、安慰剂对照、双盲、多中心、II 期临床试验(ESsCOVID)的结果。
Eur J Med Res. 2024 Aug 13;29(1):418. doi: 10.1186/s40001-024-02008-x.
3
Lab results of COVID-19 patients: Omicron delta variants.

本文引用的文献

1
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19.与 COVID-19 患者心肌 SARS-CoV-2 感染、心肌炎和心脏炎症相关的因素。
Mod Pathol. 2021 Jul;34(7):1345-1357. doi: 10.1038/s41379-021-00790-1. Epub 2021 Mar 17.
2
Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis.危重症 COVID-19 患者的血栓栓塞并发症与纤溶功能受损有关。
Crit Care. 2020 Dec 7;24(1):676. doi: 10.1186/s13054-020-03401-8.
3
COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis.
新冠病毒患者的实验室检测结果:奥密克戎和德尔塔变体
World J Virol. 2024 Jun 25;13(2):90761. doi: 10.5501/wjv.v13.i2.90761.
4
Tübingen model study: large-scale introduction of rapid antigen testing in the population and the viral dynamics of SARS-CoV-2.图宾根模型研究:在人群中大规模引入快速抗原检测和 SARS-CoV-2 的病毒动力学。
Front Public Health. 2023 Oct 24;11:1159622. doi: 10.3389/fpubh.2023.1159622. eCollection 2023.
5
The utility of serum amyloid A and other acute-phase reactants determination in ambulatory care COVID-19 patients.血清淀粉样蛋白A及其他急性期反应物测定在门诊COVID-19患者中的应用
J Med Biochem. 2023 Aug 25;42(3):492-504. doi: 10.5937/jomb0-42799.
6
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies.在以抗体缺陷为主的患者中,SARS-CoV-2 抗原刺激后的细胞因子反应。
Viruses. 2023 May 10;15(5):1146. doi: 10.3390/v15051146.
7
On-admission and dynamic trend of laboratory profiles as prognostic biomarkers in COVID-19 inpatients.住院时和动态变化的实验室指标特征可作为 COVID-19 住院患者的预后生物标志物。
Sci Rep. 2023 Apr 28;13(1):6993. doi: 10.1038/s41598-023-34166-z.
8
A two-gene marker for the two-tiered innate immune response in COVID-19 patients.COVID-19 患者双层先天免疫反应的双基因标志物。
PLoS One. 2023 Jan 17;18(1):e0280392. doi: 10.1371/journal.pone.0280392. eCollection 2023.
9
Mild COVID-19 induces early, quantifiable, persistent troponin I elevations in elder men.轻度新型冠状病毒肺炎会导致老年男性肌钙蛋白I早期、可量化且持续升高。
Front Cardiovasc Med. 2022 Dec 1;9:1053790. doi: 10.3389/fcvm.2022.1053790. eCollection 2022.
10
Long-term cardiovascular health status and physical functioning of nonhospitalized patients with COVID-19 compared with non-COVID-19 controls.与非 COVID-19 对照相比,非住院 COVID-19 患者的长期心血管健康状况和身体功能。
Am J Physiol Heart Circ Physiol. 2023 Jan 1;324(1):H47-H56. doi: 10.1152/ajpheart.00335.2022. Epub 2022 Dec 2.
危重症 COVID-19 患者的凝血功能障碍:止血参数和血栓弹力图分析显示的高凝状态。
J Thromb Thrombolysis. 2021 Apr;51(3):663-674. doi: 10.1007/s11239-020-02318-x. Epub 2020 Oct 24.
4
Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease.重新定义高敏肌钙蛋白在新冠病毒感染患者中的预后价值:合并冠状动脉疾病的重要性
J Clin Med. 2020 Oct 12;9(10):3263. doi: 10.3390/jcm9103263.
5
Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience.口服抗凝治疗与 COVID-19 临床结局:意大利多中心经验
Int J Cardiol. 2021 Jan 15;323:276-280. doi: 10.1016/j.ijcard.2020.09.001. Epub 2020 Sep 8.
6
Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible.无症状的严重急性呼吸综合征冠状病毒 2 感染:无形却不可战胜。
Int J Infect Dis. 2020 Nov;100:112-116. doi: 10.1016/j.ijid.2020.08.076. Epub 2020 Sep 3.
7
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.肌钙蛋白水平与意大利住院 2019 冠状病毒病患者死亡率的相关性:一项多中心研究结果。
JAMA Cardiol. 2020 Nov 1;5(11):1274-1280. doi: 10.1001/jamacardio.2020.3538.
8
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.新型冠状病毒肺炎肺血管内凝血病变的免疫机制
Lancet Rheumatol. 2020 Jul;2(7):e437-e445. doi: 10.1016/S2665-9913(20)30121-1. Epub 2020 May 7.
9
COVID-19 coagulopathy: An in-depth analysis of the coagulation system.COVID-19 凝血功能障碍:对凝血系统的深入分析。
Eur J Haematol. 2020 Dec;105(6):741-750. doi: 10.1111/ejh.13501. Epub 2020 Aug 19.
10
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
Immunol Res. 2020 Aug;68(4):213-224. doi: 10.1007/s12026-020-09145-5.